Kelner, M.J., Bagnell, R.D., Uglik, S.F., Montoya, M.A
References 1 FDA Label Egrifta (tesamorelin)Prescribing information for tesamorelin, FDA-approved only for reduction of excess abdominal fat in HIV-associated lipodystrophy
doi: 10.1007/BF00262746 244 EarhartRHKoellerJMDavisHL
Some clinical observations report improved hair density with consistent use
Potential in Schizophrenia and Parkinsons Disease : BPC 157 has been found to alleviate symptoms related to schizophrenia and Parkinsons disease in animal models
SRCPs also keep the hair follicles longer in the active, anagen phase and shorter in the inactive, dormant phase